BioCentury
BioCentury This Week
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android 5M+ downloads · 4.8 rating
iOS soon
Episodes
Ep. 60 - D-Day for Aducanumab: What's at stake 02.06.2021 15:10
Reach us by sending a text
Ep. 59 - KRAS to the Future; plus ARPA-H & EGFR 02.06.2021 23:45
Reach us by sending a text
Ep. 58 - LAG3 Before You Leap; plus BEE21, G20 Highlights 24.05.2021 24:46
Reach us by sending a text
Ep. 57 - Financing Scandinavia; plus IP Waivers, Long Covid & AAV Pays 10.05.2021 28:06
Reach us by sending a text
Ep. 56 - FDA’s ODAC Bind; plus NK Cell Engagers and Company Creation in Europe 04.05.2021 20:37
Reach us by sending a text
Ep. 55 - German Plays Deliver on Data, plus Accelerated Approval on Trial 27.04.2021 19:06
Reach us by sending a text
Ep. 54 - Patient Groups’ Pandemic Pain; plus Voters’ Rights and Synthetic Lethality 20.04.2021 25:51
Reach us by sending a text
Ep. 53 - Competence & Continuity at CDER; plus BIO 3.0, AACR and 2Q Preview 13.04.2021 23:45
Reach us by sending a text
Ep. 52 - Memories of John Martin, plus AACR's Hot Targets & Bio€quity Europe Preview 06.04.2021 23:51
Reach us by sending a text
Ep. 51 - Abernethy & the Obvious at FDA; Plus CEPI & EpimAb 30.03.2021 18:10
Reach us by sending a text
Ep. 50 - FTC & the Zombie Pharma Dinosaurs; Plus: RIP José Baselga, NCATS & SPACs 23.03.2021 18:50
Reach us by sending a text
Ep. 49 - Vaccine Vexed; Plus Assessing Lilly's Alzheimer's Data & PDUFA Preview 16.03.2021 20:28
Reach us by sending a text
Ep. 48 - New Modality Deep Dive; plus Sharpless Speaks & Five Prime Scores 09.03.2021 20:05
Reach us by sending a text
Ep. 47 - Whither Woodcock; plus Refresh for German Biotech & Modalities to Market 02.03.2021 25:43
Reach us by sending a text
Ep. 46 - Pipeline plays for BMS, Rigel; plus J&J's vaccine panel & access for Africa 23.02.2021 21:10
Reach us by sending a text
Ep. 45 - Start-Up Trends, COVID Variants and J&J's Adcomm 17.02.2021 17:37
Reach us by sending a text
Ep. 44 - Biotech's IPO blizzard, plus GameStop, Porter Report & Vaccine Guidance 09.02.2021 19:22
Reach us by sending a text
Ep. 43 - Europe's Next Act & the Porter Report 02.02.2021 16:51
Reach us by sending a text
Ep. 42 - Warp Speed Reflections, Master Protocols & Biden’s COVID Plan 25.01.2021 16:19
Reach us by sending a text
Ep. 41 - Biden's Science Team; Plus: Early Cancer Detection 20.01.2021 16:56
Reach us by sending a text
Ep. 40 - Investors' Picks & Access to Capital in 2021 15.01.2021 16:18
Reach us by sending a text
Ep. 39 - COVID Accountability, Biden's Bidding & Start-up Season 12.01.2021 15:16
Reach us by sending a text
Ep. 38 - Crucible of COVID, Ahoy 2021 & Cancer Deal Trends 05.01.2021 23:08
Reach us by sending a text
Ep. 37 - 2020's Silver Linings, New Year's Hopes 29.12.2020 27:30
Reach us by sending a text
Ep. 36 - Vaccines march forward & CAR Ts move earlier: a BioCentury podcast 15.12.2020 17:46
Reach us by sending a text
Similar podcasts
Listen to the BioCentury This Week podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
